MedPath

A clinical trial to study the effect of madhu(honey) kumari(aloe vera) in the management of under eye dark circles

Phase 1
Conditions
Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
Registration Number
CTRI/2021/02/031395
Lead Sponsor
purva verma self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.subjects diagnosed with periorbital hyperpigmentation will be included

2.subjects of age group 21 to 50 years will be included irrespective of their gender ,religion,and socio economic status

3.subjects who are willing to participate in the study

4.subjects with periorbital hyperpigmentation caused due to constitutional causes

Exclusion Criteria

1.subjects taking photosensitizing drugs like NASIDS,anti -histamines,oral contraceptives,sulphonamides etc

2.Chloasma/melasma,post -inflammatory hyperpigmentation will be excluded

3.smoking ,alcoholism

4.anemia

5.subjects suffering from any other systemic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.to evaluate the effect of madhu kumari lepa in periorbital hyper pigmentation <br/ ><br>2.to re-evaluate the effect of conventional topical cream (unishade plus)for periorbital hyperpigmentation <br/ ><br>3.to compare the efficacy of madhu kumari lepa with conventional topical creamTimepoint: Pre -Study assessment-0 day <br/ ><br>1st assessment -10th day <br/ ><br>1st follow up-20th day <br/ ><br>2nd follow up-30th day
Secondary Outcome Measures
NameTimeMethod
reduced dryness of the skin,reduced puffiness and reduction in wrinklesTimepoint: 1.to evaluate the effect of madhu kumari lepa in periorbital hyper pigmentation <br/ ><br>2.to re-evaluate the effect of conventional topical cream (unishade plus)for periorbital hyper pigmentation <br/ ><br>3.to compare the efficacy of madhu kumari lepa with conventinal topical cream,the duration of treatment is for 10 days,assesment will be on 10th day and follow up will be done on 20th and 30 th day
© Copyright 2025. All Rights Reserved by MedPath